Page last updated: 2024-11-05

decachlorobiphenyl

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Decachlorobiphenyl (PCB 209) is a highly chlorinated polychlorinated biphenyl (PCB) congener with ten chlorine atoms attached to the biphenyl molecule. It is a persistent organic pollutant (POP) that is highly resistant to degradation in the environment. Decachlorobiphenyl is not easily metabolized by organisms and can accumulate in the food chain. It is considered a highly toxic compound, with potential adverse effects on human health and wildlife. Decachlorobiphenyl has been associated with various health problems, including cancer, reproductive toxicity, and developmental effects. Its presence in the environment is a concern due to its persistence, bioaccumulation, and toxicity. Research on decachlorobiphenyl focuses on understanding its environmental fate and transport, its effects on organisms, and its potential risks to human health. Studies are also being conducted to develop methods for its remediation and removal from contaminated environments.'

decachlorobiphenyl: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

decachlorobiphenyl : A polychlorobiphenyl that is biphenyl in which all of the hydrogens are replaced by chlorines. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID16318
CHEMBL ID14774
CHEBI ID34666
SCHEMBL ID630082
MeSH IDM0046876

Synonyms (40)

Synonym
decachlorobiphenyl
1,1'-biphenyl, 2,2',3,3',4,4',5,5',6,6'-decachloro-
2,2',3,3',4,4',5,5',6,6'-decachloro-1,1'-biphenyl
CHEBI:34666 ,
perchlorobiphenyl
2,2',3,3',4,4',5,5',6,6'-decachlorobiphenyl
decachloro-1,1'-biphenyl
2051-24-3
pcb 209
decachlorobiphenyl, analytical standard
2,3,4,5,6,2',3',4',5',6'-decachloro-biphenyl
CHEMBL14774
1,2,3,4,5-pentachloro-6-(2,3,4,5,6-pentachlorophenyl)benzene
ai3-16253
n8al7t0att ,
unii-n8al7t0att
einecs 218-115-1
pcb no 209
AKOS015850490
2,2',3,3',4,4', 5,5',6,6'-decachlorobiphenyl
biphenyl, decachloro-
SCHEMBL630082
DTXSID4047541 ,
ONXPZLFXDMAPRO-UHFFFAOYSA-N
pcb no 209, analytical standard
pcb no. 209 10 microg/ml in cyclohexane
pcb no. 209 10 microg/ml in acetonitrile
pcb no. 209 100 microg/ml in cyclohexane
pcb no. 209 10 microg/ml in isooctane
pcb no. 209
pcb no. 209 100 microg/ml in isooctane
J-013371
decachlorobiphenyl, vial of 1 g, 99%, analytical standard
Q27116209
pcb no. 209 100 microg/ml in hexane
decachlorobiphenyl 1000 microg/ml in toluene
2,2',3,3',4,4',5,5',6,6'-pcb
dtxcid2027541
HY-115898
CS-0377498

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
polychlorobiphenylA biphenyl compound containing between 2 and 10 chlorine atoms attached to the two benzene rings.
pentachlorobenzenesAny member of the class of chlorobenzenes in which a benzene ring is substituted by five chloro groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID19262Aqueous solubility2000Bioorganic & medicinal chemistry letters, Jun-05, Volume: 10, Issue:11
Prediction of drug solubility from Monte Carlo simulations.
AID23673Partition coefficient (logP)2002Bioorganic & medicinal chemistry letters, Apr-08, Volume: 12, Issue:7
Novel estimation of lipophilic behaviour of polychlorinated biphenyls.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (38.46)18.7374
1990's1 (7.69)18.2507
2000's5 (38.46)29.6817
2010's2 (15.38)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.09 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]